MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170081666A1
SERIAL NO

15372759

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A novel network of tumorigenic prognostic factors is identified that plays a critical role in advanced pancreatic cancer (PC) pathogenesis. This interactome is interconnected through a central tumor suppressive microRNA, miR-198, which is able to both directly and indirectly modulate expression of the various members of this network to alter the molecular makeup of pancreatic tumors, with important clinical implications. When this tumor signature network is intact, miR-198 expression is reduced and patient survival is dismal; patients with higher miR-198 present an altered tumor signature network, better prognosis and increased survival. Further, according to the present disclosure, MiR-198 replacement reverses tumorigenicity in vitro and in vivo. As such, an embodiment of the disclosure is a method of treating cancer in an individual, comprising the step of increasing the level of active microRNA-198 molecules in the pancreatic cancer tumor cells of the individual by an amount sufficient to cause an improvement in the pancreatic cancer in the individual

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYLOR COLLEGE OF MEDICINEONE BAYLOR PLAZA HOUSTON TX 77030

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Changyi Houston, US 25 139
Marin-Muller, Christian League City, US 7 16
Yao, Qizhi Houston, US 29 173

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation